Secondary tabs
Record completeness
Contact details
Antonella Delmestri antonella.delmestri@ndorms.ox.ac.uk
Main
Publications
Data source publications
- The General Practice Research Database: Now and the Future (2007)
- The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations (2019)
- Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource (2012)
- The General Practice Research Database: Role in Pharmacovigilance (2004)
- Data Resource Profile Update: CPRD GOLD
Studies
List of studies that have been conducted using the data source
- DARWIN EU® Characterization of patients with chronic hepatitis B and C
- Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids: Protopic JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) Study
- DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)
- DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
- DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant
- DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
- DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations
- DARWIN EU® Rates of occurrence of treatment-related intercurrent events in patients with major depressive disorder
- DARWIN EU® Effectiveness of COVID-19 vaccines on severe COVID-19 and post acute outcomes of SARS-CoV-2 infection
- DARWIN EU® Age specific incidence rates of RSV related disease in Europe
- DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
- DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer
- DARWIN EU® Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data
- DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
- DARWIN EU® - Chondrosarcoma: patient demographics, treatments, and survival in the period 2010-2023
- DARWIN EU® - Characterising interstitial lung disease in Europe
- SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
- ADEPT: The utilisation of antiseizure medications in pregnant women, other women of childbearing potential, and men: a multi-database study from 7 European countries
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
- DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
- SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources.
- ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father
- DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe
- DARWIN EU® - Suicidality following exposure to doxycycline
- SAFETY-VAC: Phenotype proposal and rates of immunocompromised populations in real-world data sources.
- DARWIN EU® - Incidence of suicidality in patients with specific chronic skin conditions
- DARWIN EU® - Azathioprine - user characteristics
- DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - DUS Characterising STOPP criteria medication use in people with recurrent falls
- DARWIN EU® - Incidence of myoclonus in heart failure: a descriptive analysis in patients treated with sacubitril/valsartan and other treatments
- A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK (C3671038)
- DARWIN EU® -Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products
- DARWIN EU® - Suicidality incidence rates in adult male patients and in patients treated with finasteride and dutasteride
- DARWIN EU® - Characterisation of exposure to acitretin and purpura and related conditions
- DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries
- DARWIN EU® - Prescription trends of ketamine and esketamine
- DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
- DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives
- DARWIN EU® - Eye disorders in women with breast cancer treated with anastrozole, letrozole or tamoxifen
- DARWIN EU® - Characterisation of acute renal outcomes and diabetic complications among patients with concomitant use of metformin and iodinated contrast agents
- DARWIN EU® - Coverage of meningococcal vaccines in the target population in Europe
- DARWIN EU® - Descriptive study of tetanus immunoglobulin use and tetanus-prone wounds in Europe
- DARWIN EU® - Drug utilisation study in individuals with cystic fibrosis in Europe
- DARWIN EU® - Characterisation of individuals with cystic fibrosis in Europe
- Safety of mRNA COVID-19 vaccines during pregnancy
- DARWIN EU® - Characterisation of aliskiren users
- DARWIN EU® – Drug Utilisation Study of terbinafine-containing products
- DARWIN EU® – Proof-of-concept: Preparedness for annual seasonal influenza vaccine effectiveness studies - Vaccine coverage and incidence of influenza-related outcomes
- DARWIN EU® - Time to onset of thromboembolic events in adults with selected types of cancer
- DARWIN EU® - Treatment patterns in postmenopausal women in European countries: A real-world observational study
- DARWIN EU® - Assessment of immunoglobulin use in clinical practice
- DARWIN EU® - Capturing suicidality and depression related variables in databases
- DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics
- DARWIN EU® - Determinants for use of GLP1 receptor agonists – a drug utilisation study
- DARWIN EU® - Population demographics and disease frequency across the DARWIN EU® network
- DARWIN EU® - Characterising the incidence and presentation of myocarditis and/or pericarditis in Europe
- Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe – supporting international preparedness
- DARWIN EU® - Assessing the potential association between venlafaxine and heart failure in adults
- Evaluating the utilisation of Urospir® (spironolactone) in paediatric and adult patients in the United Kingdom: A drug utilisation study using the Clinical Practice Research Datalink (CPRD) database